| AA | arachidonic acid |
| CAD | coronary artery disease |
| CE | cardioembolic |
| CETP | cholesterylester transfer protein |
| COX | cyclooxygenase |
| cPLA2 | cytosolic phospholipase A2 |
| CVD | cardiovascular disease |
| CYP | cytochrome P450 |
| CysLT | cysteinyl leukotriene |
| DHA | docosahexaenoic acid |
| DPA | docosapentaenoic acid |
| EET | epoxyeicosatrienoic acid |
| END | early neurological deterioration |
| EPA | eicosapentaenoic acid |
| FA | fatty acid |
| FLAP | 5-LOX-activating protein |
| HDL | high-density lipoprotein |
| HDL-C | high-density lipoprotein cholesterol |
| HETE | hydroxyeicosatetraenoic acid |
| HS | hemorrhagic stroke |
| IDL | intermediate-density lipoprotein |
| IS | ischemic stroke |
| LA | linoleic acid |
| LDL | low-density lipoprotein |
| LDL-C | low-density lipoprotein cholesterol |
| LOX | lipoxygenase |
| Lp(a) | lipoprotein(a) |
| LT | leukotriene |
| LX | lipoxin |
| LXA4ME | lipoxin A4 methyl ester |
| NMR | nuclear magnetic resonance |
| non-HDL-C | non-high-density lipoprotein cholesterol |
| NPD1 | neuroprotectin D1 |
| OGD | oxygen-glucose deprivation |
| PAF | platelet-activating factor |
| PCSK9 | proprotein convertase subtilisin/kexin type-9 |
| PG | prostaglandin |
| PGE2 | prostaglandin E2 |
| PGI2 | prostaglandin I2, prostacyclin |
| PUFA | polyunsaturated fatty acid |
| sEH | soluble epoxide hydrolase |
| TC | total cholesterol |
| TG | triglyceride |
| TXA2 | thromboxane A2 |
| VEGF | vascular endothelial growth factor |
| VLDL | very low-density lipoprotein |